SEC Filings for Northwest Biotherapeutics Inc. (NWBO)

$ 0.20   0.001 (+0.50%) Volume: 1.84m 3:59 PM EST Feb 28, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
424B5Prospectus [Rule 424(b)(5)]3802/24/2020
4Statement of changes in beneficial ownership of securities102/05/2020
424B5Prospectus [Rule 424(b)(5)]3801/15/2020
424B5Prospectus [Rule 424(b)(5)]3801/03/2020
3Initial statement of beneficial ownership of securities112/20/2019
8-KCurrent report pursuant to Section 13 or 15(d)312/13/2019
10-QGeneral form for quarterly reports under Section 13 or 15(d)3211/12/2019
424B5Prospectus [Rule 424(b)(5)]4010/28/2019
S-3Registration statement under Securities Act of 193310510/18/2019
424B5Prospectus [Rule 424(b)(5)]4010/18/2019
10-QGeneral form for quarterly reports under Section 13 or 15(d)3308/09/2019
8-KCurrent report pursuant to Section 13 or 15(d)307/22/2019
<<
First
<
Prev
123456789101112131415